前往化源商城

N-(butan-2-yl)-4-(4-chlorophenyl)-2,3-dihydro-1,3-thiazol-2-imine

更新时间:2026-06-25 17:12:49

N-(butan-2-yl)-4-(4-chlorophenyl)-2,3-dihydro-1,3-thiazol-2-imine结构式
N-(butan-2-yl)-4-(4-chlorophenyl)-2,3-dihydro-1,3-thiazol-2-imine结构式
委托求购
常用名 N-(butan-2-yl)-4-(4-chlorophenyl)-2,3-dihydro-1,3-thiazol-2-imine 英文名 N-(butan-2-yl)-4-(4-chlorophenyl)-2,3-dihydro-1,3-thiazol-2-imine
CAS号 571150-03-3 分子量 266.79
密度 N/A 沸点 N/A
分子式 C13H15ClN2S 熔点 N/A
MSDS N/A 闪点 N/A

 名称

英文名 N-(butan-2-yl)-4-(4-chlorophenyl)-2,3-dihydro-1,3-thiazol-2-imine

 物理化学性质

分子式 C13H15ClN2S
分子量 266.79
InChIKey VVUCXSBESVXTCV-UHFFFAOYSA-N
SMILES CCC(C)NC1=NC(=CS1)C2=CC=C(C=C2)Cl

 靶点实验

查看更多实验

实验名称:Discovery of Small Molecules to Inhibit Human Cytomegalovirus Nuclear Egress
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:HCMV UL50
External Id:HMS1262
实验名称:qHTS assay for inhibitors of human lactate dehydrogenase
来源:NCGC
靶标:N/A
External Id:LDHA
实验名称:Primary qHTS Assay for Foot and Mouth Disease Virus Antivirals against NCGC Sytravon ...
来源:NCGC
External Id:stopgo-p2-SytraCBC-dual-FF
实验名称:A screen for compounds that inhibit the activity of LtaS in Staphylococcus aureus
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS979
实验名称:Primary qHTS Assay for Foot and Mouth Disease Virus Antivirals against NCGC Sytravon ...
来源:NCGC
External Id:stopgo-p2-SytraCBC-dual-Ren
实验名称:High Throughput Screening of small molecules that kill Mycobacterium tuberculosis
来源:15607
靶标:N/A
External Id:Cornell_MTB_2017
实验名称:A screen for compounds that inhibit viral RNA polymerase binding and polymerization a...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:Chain A, Poliovirus Polymerase With Gtp
External Id:HMS750
共7条,当前第1页,共1页
1
本网页内容来自不同专业数据源,如对内容有疑义,欢迎联系service1@chemsrc.com。
品牌现货直购
我想出现在这里:
QQ交流
351666998 复制
QQ交流二维码
微信交流
133 1186 9306 复制
微信交流二维码

暂无推荐供应商。我要出现这里

相关化合物: 更多...
D-Glucopyranoside methyl 2,6-dipalmitate
82933-92-4
Disodium (2-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)benzoato(2-))(2-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-5-sulphobenzoato(3-))chromate(2-)
83027-57-0
Bradykinin potentiator BPP1
83154-52-3
Sodium (2,4-dihydro-4-((2-hydroxy-5-nitrophenyl)azo)-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-))(4-hydroxy-3-((2-hydroxy-1-naphthyl)azo)benzenesulphonamidato(2-))chromate(1-)
83232-44-4
Sodium (2,4-dihydro-4-((2-hydroxy-5-nitrophenyl)azo)-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-))(N-(7-hydroxy-8-((2-hydroxy-5-nitrophenyl)azo)-1-naphthyl)acetamidato(2-))chromate(1-)
83232-45-5
Sodium (2,4-dihydro-4-((2-hydroxy-5-nitrophenyl)azo)-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-))(1-((2-hydroxy-4-nitrophenyl)azo)-2-naphtholato(2-))chromate(1-)
83249-65-4
Acetic acid, ((2-(1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-((2,3,6-trideoxy-3-((trifluoroacetyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-2-naphthacenyl)-2-oxoethyl)thio)-, ethyl ester, (2S-cis)
83291-71-8
Sodium (3-(4,5-dihydro-4-((2-hydroxy-5-nitrophenyl)azo)-3-methyl-5-oxo-1H-pyrazol-1-yl)benzenesulphonamidato(2-))(4-hydroxy-3-((2-hydroxy-1-naphthyl)azo)benzenesulphonamidato(2-))chromate(1-)
83733-00-0
Lithium (2,4-dihydro-4-((2-hydroxy-5-nitrophenyl)azo)-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-))(1-((2-hydroxy-4-nitrophenyl)azo)-2-naphtholato(2-))chromate(1-)
83733-09-9
Lithium (2,4-dihydro-4-((2-hydroxy-5-nitrophenyl)azo)-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-))(1-((2-hydroxy-5-nitrophenyl)azo)-2-naphtholato(2-))chromate(1-)
83733-10-2